Sonic Healthcare Limited (SKHHY)

Market Cap	6.97B -5.3%
Revenue (ttm)	7.52B +12.7%
Net Income	420.82M +18.4%
EPS	0.85 +15.3%
Shares Out	n/a
PE Ratio	16.56
Forward PE	16.00
Dividend	0.69 (4.94%)
Ex-Dividend Date	Sep 3, 2026

Volume	866
Open	13.89
Previous Close	13.79
Day's Range	13.89 - 13.94
52-Week Range	12.94 - 17.49
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 18, 2026

About Sonic Healthcare

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1934
• Employees: 45,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: SKHHY

Financial Performance

In fiscal year 2026, Sonic Healthcare's revenue was 10.87 billion, an increase of 12.67% compared to the previous year's 9.65 billion. Earnings were 608.29 million, an increase of 18.44%.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 7, 2026

Data Sources Report a data error